• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维肌痛:2022 年回顾一年。

Fibromyalgia: one year in review 2022.

机构信息

Rheumatology Department, ASST Fatebenefratelli Luigi Sacco University Hospital, Milan, Italy.

Rheumatology Department, ASST Fatebenefratelli Luigi Sacco University Hospital, Milan, and Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

出版信息

Clin Exp Rheumatol. 2022 Jun;40(6):1065-1072. doi: 10.55563/clinexprheumatol/if9gk2. Epub 2022 Jun 22.

DOI:10.55563/clinexprheumatol/if9gk2
PMID:35748720
Abstract

Fibromyalgia syndrome (FM) is a chronic widespread pain syndrome characterised by fatigue, sleep disturbances and many idiopathic pain symptoms. The aim of this review is to describe and summarise the most recent findings concerning the diagnosis, aetiopathogenesis and treatment of fibromyalgia syndrome published between January 2021 and January 2022 and appearing on PubMed database. In particular, last year's literature focused on the impact of COVID-19 pandemic on FM patients, on new aetiopathogenetic horizons and the last conclusions about pharmacological and non-pharmacological interventions.

摘要

纤维肌痛综合征(FM)是一种慢性广泛疼痛综合征,其特征是疲劳、睡眠障碍和许多特发性疼痛症状。本综述的目的是描述和总结 2021 年 1 月至 2022 年 1 月期间在 PubMed 数据库上发表的关于纤维肌痛综合征的最新诊断、发病机制和治疗的发现。特别是,去年的文献集中于 COVID-19 大流行对 FM 患者的影响、新的发病机制和关于药物和非药物干预的最新结论。

相似文献

1
Fibromyalgia: one year in review 2022.纤维肌痛:2022 年回顾一年。
Clin Exp Rheumatol. 2022 Jun;40(6):1065-1072. doi: 10.55563/clinexprheumatol/if9gk2. Epub 2022 Jun 22.
2
One year in review 2020: fibromyalgia.2020 年度回顾:纤维肌痛。
Clin Exp Rheumatol. 2020 Jan-Feb;38 Suppl 123(1):3-8. Epub 2020 Feb 21.
3
One year in review 2021: fibromyalgia.2021 年度回顾:纤维肌痛。
Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):3-12. doi: 10.55563/clinexprheumatol/gz4i3i. Epub 2021 May 13.
4
One year in review 2019: fibromyalgia.2019 年回顾:纤维肌痛。
Clin Exp Rheumatol. 2019 Jan-Feb;37 Suppl 116(1):3-10. Epub 2019 Feb 6.
5
One year in review 2017: fibromyalgia.2017年度回顾:纤维肌痛
Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):6-12. Epub 2017 Jun 28.
6
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome.2019年新型冠状病毒病(COVID-19)对纤维肌痛综合征的影响。
Clin Exp Rheumatol. 2021 May-Jun;39 Suppl 130(3):72-77. doi: 10.55563/clinexprheumatol/dnxtch. Epub 2020 Nov 16.
7
Fibromyalgia: a critical digest of the recent literature.纤维肌痛症:近期文献的批判性综述。
Clin Exp Rheumatol. 2011 Nov-Dec;29(6 Suppl 69):S1-11. Epub 2012 Jan 9.
8
Quantitative assessment of the "inexplicability" of fibromyalgia patients: a pilot study of the fibromyalgia narrative of "medically unexplained" pain.对纤维肌痛患者“无法解释”的定量评估:对纤维肌痛患者“医学无法解释”疼痛的叙事的初步研究。
Clin Rheumatol. 2012 Oct;31(10):1455-61. doi: 10.1007/s10067-012-2029-x. Epub 2012 Jul 22.
9
Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia?系统性红斑狼疮和干燥综合征中的疲劳和广泛疼痛:是炎症性疾病的症状还是相关纤维肌痛症的症状?
Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):117-21. Epub 2012 Dec 14.
10
One year in review 2016: fibromyalgia.2016年度回顾:纤维肌痛
Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S145-9. Epub 2016 Apr 22.

引用本文的文献

1
Retrospective Evaluation of L-Acetyl Carnitine and Palmitoylethanolamide as Add-On Therapy in Patients with Fibromyalgia and Small Fiber Neuropathy.对L-乙酰肉碱和棕榈酰乙醇胺作为纤维肌痛和小纤维神经病变患者附加治疗的回顾性评估
Pharmaceutics. 2025 Jul 31;17(8):1004. doi: 10.3390/pharmaceutics17081004.
2
Acupressure attenuates fibromyalgia central sensitization via MAPK phosphorylation-mediated neuroinflammation regulation.指压通过丝裂原活化蛋白激酶磷酸化介导的神经炎症调节减轻纤维肌痛中枢敏化。
J Orthop Surg Res. 2025 Jul 8;20(1):622. doi: 10.1186/s13018-025-05986-8.
3
Accurate Chemogenetics Determines Electroacupuncture Analgesia Through Increased CB1 to Suppress the TRPV1 Pathway in a Mouse Model of Fibromyalgia.
精确的化学遗传学通过增加CB1以抑制纤维肌痛小鼠模型中的TRPV1通路来确定电针镇痛效果。
Life (Basel). 2025 May 20;15(5):819. doi: 10.3390/life15050819.
4
Possible Interaction of Suramin with Thalamic P2X Receptors and NLRP3 Inflammasome Activation Alleviates Reserpine-Induced Fibromyalgia-Like Symptoms.苏拉明与丘脑P2X受体的可能相互作用及NLRP3炎性小体激活减轻利血平诱导的纤维肌痛样症状
J Neuroimmune Pharmacol. 2025 May 7;20(1):51. doi: 10.1007/s11481-025-10207-4.
5
Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia.纤维肌痛患者中miR-217和miR-532的生化分析。
Eur J Med Res. 2025 Feb 7;30(1):85. doi: 10.1186/s40001-025-02330-y.
6
Osteoarthritis and Degree of Fatigue are Associated with Pain Levels in Patients with Fibromyalgia Syndrome: A Cross-Sectional Study of 394 Patients.骨关节炎和疲劳程度与纤维肌痛综合征患者的疼痛水平相关:一项对394例患者的横断面研究。
Int J Gen Med. 2025 Jan 31;18:497-507. doi: 10.2147/IJGM.S503902. eCollection 2025.
7
A Comprehensive Analysis of Fibromyalgia and the Role of the Endogenous Opioid System.纤维肌痛症及内源性阿片系统作用的综合分析
Biomedicines. 2025 Jan 11;13(1):165. doi: 10.3390/biomedicines13010165.
8
A safety and feasibility randomized placebo controlled trial exploring electroencephalographic effective connectivity neurofeedback treatment for fibromyalgia.一项探索脑电图有效连接性神经反馈疗法治疗纤维肌痛的安全性和可行性随机安慰剂对照试验。
Sci Rep. 2025 Jan 2;15(1):209. doi: 10.1038/s41598-024-83776-8.
9
Effectiveness of a brief multicomponent intervention to improve physical activity level and functional capacity in fibromyalgia and chronic fatigue syndrome (Synchronize+).一种简短的多组分干预措施对改善纤维肌痛和慢性疲劳综合征(Synchronize+)患者身体活动水平和功能能力的有效性。
Front Physiol. 2024 Dec 9;15:1441076. doi: 10.3389/fphys.2024.1441076. eCollection 2024.
10
Comparison between Conditioned Pain Modulation Paradigms Using Cold Pressor Conditioning Stimulus versus Ischemic Pressure Stimulus in Women with Fibromyalgia and Its Impact on Clinical Status: A Cross-Sectional Study.纤维肌痛女性中使用冷加压条件刺激与缺血性压力刺激的条件性疼痛调制范式比较及其对临床状态的影响:一项横断面研究。
Biomedicines. 2024 Sep 29;12(10):2222. doi: 10.3390/biomedicines12102222.